New US dealer

RNS Number : 7422F

Surgical Innovations Group PLC

29 May 2013

 



Surgical Innovations Group plc

("SI" or the "Company")

New US dealer

Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces the appointment of a  US distributor, the first new  US dealer since the appointment of Rick Barnett as President of US Sales and Operations.

The distributor will promote SI's Logi™ Range and YelloPort+plus™ products across Indiana, Kentucky and Ohio under the terms of a three year distribution agreement.

The established distributor is based in Indianapolis and through its dedicated sales team will cover in excess of 430 hospitals across the three designated US States.  

Graham Bowland, Chief Executive Officer for Surgical Innovations, said: "This contract is evidence of SI's strategy to penetrate the US market and optimise the opportunity located there. Rick Barnett was appointed at the beginning of the month and in this short period of time has already secured this new distributor, which will help develop SI's presence in the US. Other US dealer agreements are in the pipeline and the market will be updated accordingly."

- ENDS -

Enquiries:

Surgical Innovations Group plc		www.sigroupplc.com
Doug Liversidge, Non-Executive Chairman		Tel: [phone]
Graham Bowland, Chief Executive Officer		[e-mail]
Panmure Gordon (Nominated Advisor & Broker)		www.panmure.com
Freddy Crossley / Fred Walsh (Corporate Finance)		Tel: [phone]
Adam Pollock/ Victoria Boxall (Corporate Broking)
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

Notes to Editors:

About Surgical Innovations Group plc

Surgical Innovations Group plc specialises in the design and manufacture of creative solutions for minimally invasive surgery (MIS) and industrial markets. 

As well as manufacturing single-use and reusable instruments for the laparoscopic market, the Group has pioneered its flagship Resposable® instrumentation combining both single use and reusable components, ensuring ongoing revenue streams and delivering the optimum procedure performance to cost ratio.

Over 100 people are employed at the Group's 32,000 square feet facility in Leeds, with in-house design, plastic injection moulding and manufacturing equipment, producing products to the highest quality standards.

The Group's patented products are sold through three main channels:

SI brand	Through an established network of distribution partners, Surgical Innovations branded products are sold in major medical markets including North America, Britain, South East Asia, Australasia and the Indian subcontinent.
OEM and IP	The Group supplies large medical device companies on an OEM basis, generating both sales and IP royalty fees.  Clients include Teleflex Medical, Olympus and CareFusion.
Industrial	SI's patented segment technology has been applied to the industrial market enabling customers to undertake inspection and maintenance of large-scale equipment, in situ with minimum disassembly and downtime.

For more information, see www.sigrouplplc.com

 

END

 

 

MSCSEDEEAFDSESI